Acurx Pharmaceuticals, Inc. Announces Closing of up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Go back to Acurx Pharmaceuticals, Inc. Announces Closing of up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
(NASDAQ: ACXP) Delayed: 1.44 -0.03 (2.04%)
Previous Close $1.47    52 Week High
Open $1.47    52 Week Low
Day High $1.52    P/E N/A 
Day Low $1.42    EPS
Volume 42,904